RxDoctor Payments Data

Robert Cook, MD

Family Medicine · Plano, TXNPI 1568407690

Payments from drug & device makers

$10,033in general payments, 2019–2025

Across 612 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • Amgen$796
  • GSK$777
  • Lilly USA, LLC$647
  • Novo Nordisk$509
  • plus $5K from 53 others

What the payments were for

  • Food & beverage$10,033100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)98$1,517
Pfizer58$1,006
Amgen51$796
GSK54$777
Lilly USA, LLC47$647
Novo Nordisk32$509
AstraZeneca(2 entities)29$453
Otsuka America Pharmaceutical, Inc.16$331
Merck21$329
Novartis14$251
Boehringer Ingelheim14$235
Takeda Pharmaceuticals U.S.A., Inc.14$218
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$217
Esperion Therapeutics, Inc.15$206
Genentech USA, Inc.9$174
Amarin Pharma, Inc.12$171
Bausch Health US, LLC3$164
Exact Sciences8$158
Biohaven Pharmaceuticals, Inc.7$138
Biohaven Pharmaceutical Holding Company Ltd.9$132
Abbott4$100
Upsher-smith Laboratories LLC6$96
Currax Pharmaceuticals LLC6$87
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$84
Antares Pharma, Inc.5$80
Axsome Therapeutics, Inc.3$76
Verity Pharmaceuticals Inc.3$70
Bayer4$65
Teva Pharmaceuticals USA, Inc.3$59
Kowa Pharmaceuticals America, Inc.4$58
Johnson & Johnson3$56
Inari Medical, Inc.2$49
Biotronik NRO, Inc.1$45
Corium, LLC2$44
Nabriva Therapeutics, PLC3$44
Mayne Pharma Commercial LLC2$41
Sanofi Pasteur Inc.2$38
Seqirus USA Inc2$37
Paratek Pharmaceuticals, Inc.2$37
Medtronic2$36
IBSA Pharma Inc.2$33
Clarus Therapeutics Inc.2$31
Althera Pharmaceuticals LLC2$29
Eisai Inc.2$29
Melinta Therapeutics, LLC2$28
Arbor Pharmaceuticals, Inc.2$28
Idorsia Pharmaceuticals US Inc1$25
Amneal Pharmaceuticals LLC2$24
Radius Health, Inc.1$20
Noven Therapeutics, LLC1$20
Gilead1$19
Promius Pharma LLC1$18
Itamar Medical Inc1$18
Astellas Pharma US Inc1$16
Shire North American Group Inc1$15
Metuchen Pharmaceuticals1$14
Supernus Pharmaceuticals, Inc.1$13
Evoke Pharma, Inc.1$12
Adlon Therapeutics L.p.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,033 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$183,831
Medicare patients
510
Services billed
6,821

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$50,031
EliquisApixaban33$47,833
JardianceEmpagliflozin30$31,709
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$30,618
JanuviaSitagliptin Phosphate21$28,054
XareltoRivaroxaban21$20,070
LinzessLinaclotide12$14,130
ViberziEluxadoline13$10,248
Breo ElliptaFluticasone/Vilanterol12$9,455
SynthroidLevothyroxine Sodium81$6,499
MovantikNaloxegol Oxalate11$4,648
Rosuvastatin Calcium344$3,198
Potassium Chloride85$2,960
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,929
PaxlovidNirmatrelvir/Ritonavir13$2,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$1,006$50,69146 claims
Novo NordiskOzempic$509$50,03144 claims
GSKTrelegy Ellipta, Breo Ellipta$777$40,07336 claims
Boehringer IngelheimJardiance$235$31,70930 claims
AbbVieLinzess, Viberzi, Synthroid$1,517$30,877106 claims
MerckJanuvia$329$28,05421 claims
Johnson & JohnsonXarelto$56$20,07021 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$24$2,321241 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →